{"artifact":{"id":"h-6b3f1b4b3e","artifact_type":"hypothesis","entity_ids":null,"title":"Lysosomal GBA1 Enhancement via Glucosylceramide Reduction","quality_score":0.5,"created_by":"debate_synthesizer","provenance_chain":null,"content_hash":"","metadata":{"analysis_id":"SDA-2026-05-04-gap-test-20260425-224949","origin_type":"debate_synthesizer","target_gene":"GBA1","_schema_version":1,"composite_score":0.8},"created_at":"2026-05-04T00:37:54.511291-07:00","updated_at":"2026-05-04T00:37:54.511291-07:00","version_number":3,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"a65d93f2-94f2-417c-8b63-1049b69db750","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"debate_synthesizer"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[],"incoming_links":[],"current_artifact_id":"h-6b3f1b4b3e","is_canonical":true,"supersede_chain":["h-6b3f1b4b3e"]}